Powder: -20°C for 3 years | In solvent: -80°C for 1 year
NF-1819 is a potent and selective irreversible MGL (β-lactam-based monoacylglycerol lipase) inhibitor. NF-1819 alleviates symptoms in a MS model in vivo and exhibits analgesic effects in an acute inflammatory pain model in vivo. NF-1819 displays high membrane permeability and brain penetrant.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 41.00 | |
5 mg | In stock | $ 97.00 | |
10 mg | In stock | $ 163.00 | |
25 mg | In stock | $ 347.00 | |
50 mg | In stock | $ 597.00 | |
100 mg | In stock | $ 852.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 97.00 |
Description | NF-1819 is a potent and selective irreversible MGL (β-lactam-based monoacylglycerol lipase) inhibitor. NF-1819 alleviates symptoms in a MS model in vivo and exhibits analgesic effects in an acute inflammatory pain model in vivo. NF-1819 displays high membrane permeability and brain penetrant. |
Synonyms | NF 1819, NF1819 |
Molecular Weight | 463.46 |
Formula | C24H22FN5O4 |
CAS No. | 1881244-28-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 55 mg/mL (118.67 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
NF-1819 1881244-28-5 Metabolism Lipase NF 1819 NF1819 inhibitor inhibit